Servier is an independent Group governed by a non-profit foundation, with our headquarters in France (Suresnes). Operating in 150 countries, we have 20,000 employees worldwide.
Entirely independent, we invest each year 20% of our revenue from brand-named medicines, into Research and Development, and all profits are used for further development.
Our R&D is focused on 3 main therapeutic areas:
We are 6th leading pharmaceutical group in cardiology and 1st in hypertension, worldwide.
We have 16 chemical and pharmaceutical manufacturing centers worldwide which produce more than 600 million boxes of medicines each year.
We have been committed to therapeutic progress to serve patient needs with the help of healthcare professionals. We strive to transmit to future generations a world that can ensure access to quality health care for all.
Traditionally, Servier is a worldwide market leader on hypertension, cardiology, diabetology and venous diseases, but recently the emphasis has shifted to include research in oncology and haematology with innovative targeted treatments to address high unmet medical needs.
Servier Bulgaria has been present in the Bulgarian market since 1993 with a team of 80 employees and 41 registered medicaments. Servier Bulgaria has built strong partnerships over those 33 years with scientific leaders, healthcare providers and patient associations in its fields. Servier Bulgaria is also dedicated to leaving a positive and sustainable impact on society and environment.
Find out more on our website: www.servier.bg
Or following our social media: https://www.linkedin.com/showcase/servier-bulgaria/
